LP s obsahem risankizumabu 2026
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Procurement documents were not analyzed; may contain critical qualification, technical, and contractual terms.
Award solely on price may lead to margin pressure; ensure cost competitiveness.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 25.8M estimated value
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Repeated deliveries of medicinal products with active substance risankizumab.
- Contract duration: 36 months.
Show full summary
Open tender by Fakultní nemocnice Olomouc for repeated supplies of medicinal products containing risankizumab (ATC group immunosuppressive agents). Single lot, 36-month contract, estimated value CZK 25,819,875. Award based solely on lowest price. Submission deadline 2026-07-20, electronic submission required, language Czech. No procurement documents were analyzed.
Risks
Procurement documents were not analyzed; may contain critical qualification, technical, and contractual terms.
Award solely on price may lead to margin pressure; ensure cost competitiveness.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Supplies of immunosuppressive agents (CPV 33652300).
Administrative
- Electronic submission required.
- Submission language: Czech.
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Name
Fakultní nemocnice Olomouc
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Lots (1)
LOT-0001
LP s obsahem risankizumabu 2026
Repeated supplies of medicinal products containing risankizumab.
CZK 25.8M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků s obsahem účinné látky risankizumab.
Procurement Details
- Publication date
- 15 Jun 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 413345-2026
Documents (1)
Similar tenders
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Immunosuppressive agents – Dostawa środków immunosupresyjnych, produktów leczniczych dla układu nerwowego, produktów leczniczych dla organów zmysłów, środków leczniczych dla układu oddechowego, produktów leczniczych dla przewodu pokarmowego i metabolizmu, produktów leczniczych stosowanych przy cukrzycy, insuliny, płynów dożylnych, ogólnoustrojowych preparatów hormonalnych, z wyłączeniem hormonów płciowych oraz różnych...
Czechia – Immunosuppressive agents – LP s obsahem certolizumab pegolu 2026
Czechia – Immunosuppressive agents – Ixekizumab
Czechia – Immunosuppressive agents – Léčivé přípravky s obsahem kladribinu a guselkumabu 200 mg
Czechia – Immunosuppressive agents – LP s obsahem baricitinibu 2026
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
Procurement documents were not analyzed; may contain critical qualification, technical, and contractual terms.
Award solely on price may lead to margin pressure; ensure cost competitiveness.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications